Rhabdomyolysis in a patient with MELAS syndrome

European Neurology

Volumn 50, Issue 2, 2003, Pages 123-124

  Kwon, Jee Hyun ^a   Kim, Jong S ^a,b  

^a University of Ulsan   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BICARBONATE; CARBAMAZEPINE; CLONAZEPAM; FUROSEMIDE;

ADULT; APHASIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; GENE MUTATION; HEADACHE; HOMONYMOUS HEMIANOPIA; HUMAN; HUMAN TISSUE; HYDRATION; LABORATORY TEST; MELAS SYNDROME; MUSCLE BIOPSY; PHYSICAL EXAMINATION; POINT MUTATION; PRIORITY JOURNAL; RHABDOMYOLYSIS; SEIZURE; SPEECH DISORDER; TREATMENT OUTCOME; VISUAL HALLUCINATION; VOMITING;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MELAS SYNDROME; RHABDOMYOLYSIS;

EID: 0141679670     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072517     Document Type: Article

References (7)

1. Warren JD, Blumbergs PC, Thompson PD: Rhabdomyolysis: A review. Muscle Nerve 2002;25:332-347.
2. Gabow PA, Kaehny WD, Kelleher SP: The spectrum of rhabdomyolysis. Medicine (Baltimore) 1982;61:141-152.
3. Chariot P, Abadia R, Agnus D, Danan C, Charpentier C, Gherardi RK: Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome. Am J Med 1993;94:109-110.
4. Hara H, Wakayama Y, Kouno Y, Yamada H, Tanaka M, Ozawa T: Acute peripheral neuropathy, rhabdomyolysis and severe lactic acidosis associated with 3243 A to G mitochondrial DNA mutation. J Neurol Neurosurg Psychiatry 1994;57:1545-1546.
5. Lofberg M, Jankala H, Paetau A, Harkonen M, Somer H: Metabolic causes of recurrent rhabdomyolysis. Acta Neurol Scand 1998;98:268-275.
6. Flierl A, Reichmann H, Seibel P: Pathophysiology of the MELAS 3243 transition mutation. J Biol Chem 1997;272:27189-27196.
7. Hanna MG, Nelson IP: Genetics and molecular pathogenesis of mitochon-drial respiratory chain diseases. Cell Mol Life Sci 1999;55:691-706.